Avrobio | Betriebsergebnis

Operating Profit Veränderung Datum
Adcock Ingram Holdings ZAR 541.49M 52.55M 2023-06
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Ecofibre AUD -3356000 20.27M 2023-06
Gilead Sciences USD 1.61B 1.01B 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Kangmei Pharma CNY -21752960 44.94M 2023-09
Knight Therapeutics CAD 2.29M 1.5M 2023-09
Laboratorios Farma EUR 85.28M 66.78M 2023-06
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -11427000 4.13M 2023-06
Neuren Pharmaceuticals AUD 48.83M 41.89M 2023-06
Organigram Holdings CAD -219637000 208.87M 2023-03
Pfizer USD -6551000000 3.61B 2023-12
Pharma Mar EUR -184000 4.23M 2023-09
Probiotec AUD 8.03M 492.24K 2023-06
Qiagen NV USD 97.18M 8.25M 2023-09
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Sartorius EUR 80M 45.4M 2023-09
Sino Biopharmaceutical CNY 3.75B 797.83M 2023-06
Takeda JPY -49342000000 217.91B 2023-09
Zz Pientze Pharmaceu 1.04B 113.61M 2023-09



Avrobio Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.